Last updated on February 2020

Phase 3 Study of OTO-104 in Subjects With Unilateral Meniere's Disease

Brief description of study

The purpose of this study is to evaluate the effectiveness of OTO-104 for the treatment of Meniere's disease.

Clinical Study Identifier: NCT03664674

Find a site near you

Start Over

HNO Zentrum am Kudamm

Berlin, Germany
  Connect »